Date: Dec. 6–9, 2025
Location: Orlando, FL
Booth: #1971
NeoGenomics, a market leader in hematologic cancer testing for over 20 years, provides comprehensive and guideline-driven solutions that accurately address patients’ diagnostic needs.
At the 2025 ASH Annual Meeting, NeoGenomics is showcasing our hematology portfolio with solutions that accelerate clinical decisions and improve outcomes for cancer patients.